Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,878 | 4,278 | 23,550 | 43,145 | 70,903 |
| TOTAL | $9,686 | $5,194 | $26,273 | $45,596 | $72,497 |
| Non-Current Assets | |||||
| PPE Net | 78 | 159 | 272 | 275 | 338 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 1,214 | 424 | 524 | 403 | 107 |
| TOTAL | $12,440 | $11,731 | $11,944 | $11,826 | $11,593 |
| Total Assets | $22,126 | $16,925 | $38,217 | $57,422 | $84,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,854 | 5,359 | 6,815 | 4,819 | 3,622 |
| TOTAL | $6,854 | $5,359 | $6,815 | $4,819 | $3,622 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 266 | 358 | 5,329 | 412 | 1,475 |
| TOTAL | $266 | $358 | $5,329 | $412 | $1,475 |
| Total Liabilities | $7,120 | $5,717 | $12,144 | $5,231 | $5,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,336 | 560 | 6 | 76 | 76 |
| Common Shares | 3 | N/A | 33 | 29 | 29 |
| Retained earnings | -206,004 | -172,444 | -131,604 | -101,835 | -72,810 |
| Other shareholders' equity | 10 | -41 | -9 | 12 | 41 |
| TOTAL | $15,006 | $11,208 | $26,073 | $52,191 | $78,993 |
| Total Liabilities And Equity | $22,126 | $16,925 | $38,217 | $57,422 | $84,090 |